United States · Platforms & data · Seeking Alpha
GLP-1s can save health system money if priced below $350 a month: analysis
Detailed summary
CVS Health's Aetna claims analysis finds GLP-1s priced below $350 a month could yield net savings for payors through reduced health care use. Read more here.
An analysis of insurance claims data found that if GLP-1 medications for weight loss and diabetes are priced below $350, it results in net savings for payors, such as employers and plan sponsors, through reduced use of health care services that result.
Opening of the article, excerpted from Seeking Alpha. To read the rest, open the article on the publisher's site.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (seekingalpha.com)
